The Home of LiveLong
HeartLung (heartlung.ai) earns a Brand Analyzer score of 67 out of 100, placing it in the Developing tier among SaaS brands, Healthcare brands. Among 12358 SaaS brands analyzed, HeartLung ranks in the 36th percentile (category average 69, leader 97). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 88/100, Digital Presence 76/100, Visual Identity 90/100, Messaging Clarity 95/100, Trust Foundation 58/100, AI Discoverability 84/100, Brand Authority 18/100.
HeartLung (heartlung.ai) is an AI-enabled medical SaaS company focused on opportunistic early disease detection using non-contrast chest CT scans. Its FDA-cleared AI analyzes routine scans to identify heart disease, lung cancer, osteoporosis, fatty liver disease, and other conditions, generating up to 10 actionable reports per scan. The platform serves both direct-to-consumer (D2C) patients and business-to-business (B2B) healthcare providers, positioning itself as a broad multisystem disease detection solution.
| Brand Name | HeartLung |
|---|---|
| Domain | heartlung.ai |
| Industry | SaaS, Healthcare |
| Main Competitors | Viz.ai, Aidoc, Veracyte, Riverain Technologies, Intelerad, Subtle Medical (68/100) |
Moz Domain Authority 22/100 vs category average 28 / leader 99 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "HeartLung.AI is an AI-enabled medical SaaS company focused on early detection of heart disease, lung cancer, osteoporosis, fatty liver disease and other conditions found in one non…" (Meta description: 45 words. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, YouTube, GitHub; no detected presence on X (Twitter), Facebook, Instagram - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
HeartLung scores 29/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
HeartLung has a weak AI-visibility profile at 29/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (56/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 22/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
HeartLung offers an AI-enabled medical SaaS platform that analyzes non-contrast chest CT scans. Its core product generates up to 10 actionable diagnostic reports per scan, covering conditions such as heart disease, lung cancer, osteoporosis, and fatty liver disease. The platform is available in two commercial models: a direct-to-consumer (D2C) offering for individual patients and a business-to-business (B2B) offering for physicians and healthcare providers.
Sources: HeartLung official site
HeartLung's main competitors include Viz.ai, Aidoc, Veracyte, Riverain Technologies, Intelerad. These companies compete in the SaaS space for similar customers, offering comparable products or services.
Sources: HeartLung official site
HeartLung and Subtle Medical are competitors in SaaS. Brand Analyzer scores HeartLung at 67/100 and Subtle Medical at 68/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: HeartLung official site
HeartLung is an AI-enabled medical SaaS company operating at heartlung.ai. It is built around FDA-cleared artificial intelligence technology designed to analyze non-contrast chest CT scans for opportunistic, early detection of multiple diseases. The company serves both individual patients through a direct-to-consumer model and healthcare organizations through a business-to-business model, positioning itself as a comprehensive multisystem screening platform within the healthcare and SaaS categories.
Sources: HeartLung official site
HeartLung uses FDA-cleared AI to analyze routine non-contrast chest CT scans and detect multiple hidden conditions simultaneously, including heart disease, lung cancer, osteoporosis, and fatty liver disease. From a single scan, the platform generates up to 10 actionable reports intended for both physicians and patients. By opportunistically screening for conditions that might otherwise be missed, it aims to enable earlier intervention and improve health outcomes across multiple organ systems.
Sources: HeartLung official site
Popular alternatives to HeartLung include Viz.ai, Aidoc, Veracyte, Riverain Technologies, Intelerad. Each is an established option in the SaaS space; the best fit depends on your specific needs, budget, and required features.
Sources: HeartLung official site
HeartLung has limited AI-search visibility, scoring 29/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 49, recommendation 56). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: HeartLung official site
HeartLung serves two primary customer segments. On the B2B side, its users include physicians and healthcare providers who use the platform's actionable reports to support clinical decision-making and patient care. On the D2C side, individual patients who have undergone or are seeking chest CT imaging can access HeartLung's screening insights directly. This dual-market approach allows the platform to reach both institutional healthcare settings and health-conscious consumers.
Sources: HeartLung official site
HeartLung is known for offering the broadest opportunistic multisystem disease detection from a single non-contrast chest CT scan. Its FDA-cleared AI platform is designed to identify conditions across multiple body systems - including cardiovascular, pulmonary, skeletal, and hepatic - from one imaging study. The company is also noted for providing up to 10 actionable reports per scan and for serving both direct-to-consumer patients and B2B healthcare providers within a single platform.
Sources: HeartLung official site
HeartLung scores 56/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest SaaS options. Recommendation depends on crawlability, structured data, and category authority.
Sources: HeartLung official site
Based on the available facts, HeartLung states that its AI technology is FDA-cleared, which indicates it has undergone a formal regulatory review process by the U.S. Food and Drug Administration for its intended medical use. FDA clearance is a recognized credentialing milestone in the medical device and health AI industry. No additional independent reviews, certifications, or audit results are provided in the known facts, so no further trustworthiness claims can be substantiated here.
Sources: HeartLung official site
HeartLung can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: HeartLung official site
Ranked closest to HeartLung: Health Here (67/100), HashrateUp (67/100), Heera Software (67/100), Hertzler GainSeeker (67/100).
A step up - brands to learn from: ZyG (71/100), Zuant (71/100).
Category leader: Accenture (97/100).